Avanos Medical, Inc. (AVNS)
Jul 27, 2026 - AVNS was delisted (reason: acquired by American Industrial Partners)
24.99
+0.01 (0.04%)
Inactive · Last trade price on Jul 24, 2026

Avanos Medical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
65.689.8107.787.7127.7118.5
Cash & Short-Term Investments
65.689.8107.787.7127.7118.5
Cash Growth
-32.37%-16.62%22.80%-31.32%7.76%6.28%
Accounts Receivable
102.9103.7127.9128.7155.7118.2
Other Receivables
0.10.14.914.112.213
Receivables
103103.8132.8142.8167.9131.2
Inventory
141.3148138.8163.2132.3159.3
Prepaid Expenses
15.113.814.128.813.918.6
Other Current Assets
---64.5182.3-
Total Current Assets
325355.4393.4487624.1427.6
Property, Plant & Equipment
150.5141144.8144146.1206.7
Goodwill
394394.9455.6796.1760.3801.6
Other Intangible Assets
114.7117.8112.3239.5234.2141.2
Long-Term Deferred Tax Assets
3333.124.96.54.610
Other Long-Term Assets
32.731.523.219.317.616.5
Total Assets
1,0501,0741,1541,6921,7871,604

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
52.355.554.356.367.956.4
Accrued Expenses
5174.473.376.576.665.1
Current Portion of Long-Term Debt
10.910.29.48.66.2-
Current Portion of Leases
10.48.210.912.81214.7
Current Income Taxes Payable
6.616.91816.721.23
Other Current Liabilities
---63.77.1-
Total Current Liabilities
131.2165.2165.9234.6191139.2
Long-Term Debt
87.390.3125.3159.4226.3130
Long-Term Leases
29.820.424.628.332.542.8
Long-Term Deferred Tax Liabilities
5.66.15.523.825.411.9
Other Long-Term Liabilities
14.113.54.41020.59.1
Total Liabilities
268295.5325.7456.1495.7333

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.50.50.50.50.50.5
Additional Paid-In Capital
1,6961,6921,6791,6641,6461,629
Retained Earnings
-774.8-779.9-707-314.9-253.1-303.6
Treasury Stock
-103.6-102.3-99-85.9-66.8-21.3
Comprehensive Income & Other
-36-32-44.6-27-35.8-33.8
Shareholders' Equity
782.1778.2828.51,2361,2911,271
Total Liabilities & Equity
1,0501,0741,1541,6921,7871,604

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
138.4129.1170.2209.1277187.5
Net Cash (Debt)
-72.8-39.3-62.5-121.4-149.3-69
Net Cash Growth
------
Net Cash Per Share
-1.57-0.85-1.36-2.61-3.16-1.42
Filing Date Shares Outstanding
46.8246.54643.1646.647.32
Total Common Shares Outstanding
46.6746.4645.9643.1344.447.63
Working Capital
193.8190.2227.5252.4433.1288.4
Book Value Per Share
16.7616.7518.0328.6629.0826.68
Tangible Book Value
273.4265.5260.6200.7296.7327.8
Tangible Book Value Per Share
5.865.725.674.656.686.88
Land
1.31.31.11.31.11.1
Buildings
39.940.140.63837.248
Machinery
201.9199.1186.3182.8168.7223.2
Construction In Progress
25.42521.41816.432
SEC Filings: 10-K · 10-Q